{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:50:14Z","timestamp":1793764214382,"version":"4.6.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["APP461645"],"award-info":[{"award-number":["APP461645"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["APP461645"],"award-info":[{"award-number":["APP461645"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["APP461645"],"award-info":[{"award-number":["APP461645"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["APP461645"],"award-info":[{"award-number":["APP461645"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["APP461645"],"award-info":[{"award-number":["APP461645"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["APP461645"],"award-info":[{"award-number":["APP461645"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["APP461645"],"award-info":[{"award-number":["APP461645"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["APP461645"],"award-info":[{"award-number":["APP461645"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["APP461645"],"award-info":[{"award-number":["APP461645"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["APP461645"],"award-info":[{"award-number":["APP461645"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["APP461645"],"award-info":[{"award-number":["APP461645"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010785","name":"Canada First Research Excellence Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41380-024-02816-x","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T15:40:53Z","timestamp":1730994053000},"page":"2049-2058","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evidence of altered monoamine oxidase B, an astroglia marker, in early psychosis and high-risk state"],"prefix":"10.1038","volume":"30","author":[{"given":"Kankana","family":"Nisha Aji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nittha","family":"Lalang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-6179","authenticated-orcid":false,"given":"Christian","family":"Ramos-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3509-0400","authenticated-orcid":false,"given":"Reza","family":"Rahimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4960-756X","authenticated-orcid":false,"given":"Naguib","family":"Mechawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4075-2736","authenticated-orcid":false,"given":"Gustavo","family":"Turecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Chartrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9901-1484","authenticated-orcid":false,"given":"Isabelle","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4684-5052","authenticated-orcid":false,"given":"Jeffrey H.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0075-2918","authenticated-orcid":false,"given":"Pablo M.","family":"Rusjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6667-7928","authenticated-orcid":false,"given":"Romina","family":"Mizrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"2816_CR1","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn1722","volume":"6","author":"A Volterra","year":"2005","unstructured":"Volterra A, Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci. 2005;6:626\u201340.","journal-title":"Nat Rev Neurosci"},{"key":"2816_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.conb.2017.08.017","volume":"47","author":"AP Bosworth","year":"2017","unstructured":"Bosworth AP, Allen NJ. The diverse actions of astrocytes during synaptic development. Curr Opin Neurobiol. 2017;47:38\u201343.","journal-title":"Curr Opin Neurobiol"},{"key":"2816_CR3","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3389\/fpsyt.2018.00544","volume":"9","author":"YY Mei","year":"2018","unstructured":"Mei YY, Wu DC, Zhou N. Astrocytic regulation of glutamate transmission in Schizophrenia. Front Psychiatry. 2018;9:544.","journal-title":"Front Psychiatry"},{"key":"2816_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41380-018-0226-y","volume":"25","author":"F Petrelli","year":"2020","unstructured":"Petrelli F, Dall\u00e9rac G, Pucci L, Cal\u00ec C, Zehnder T, Sultan S, et al. Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments. Mol Psychiatry. 2020;25:732\u201349.","journal-title":"Mol Psychiatry"},{"key":"2816_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12781","volume":"53","author":"Y Chen","year":"2020","unstructured":"Chen Y, Qin C, Huang J, Tang X, Liu C, Huang K, et al. The role of astrocytes in oxidative stress of central nervous system: a mixed blessing. Cell Prolif. 2020;53:e12781.","journal-title":"Cell Prolif"},{"key":"2816_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/23982128211009148","volume":"5","author":"T Notter","year":"2021","unstructured":"Notter T. Astrocytes in schizophrenia. Brain Neurosci Adv. 2021;5:23982128211009148.","journal-title":"Brain Neurosci Adv"},{"key":"2816_CR7","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/glia.24221","volume":"70","author":"EC de Oliveira Figueiredo","year":"2022","unstructured":"de Oliveira Figueiredo EC, Cal\u00ec C, Petrelli F, Bezzi P. Emerging evidence for astrocyte dysfunction in schizophrenia. Glia. 2022;70:1585\u2013604.","journal-title":"Glia"},{"key":"2816_CR8","doi-asserted-by":"publisher","first-page":"e2410684","DOI":"10.1001\/jamanetworkopen.2024.10684","volume":"7","author":"M Kim","year":"2024","unstructured":"Kim M, Choi W, Choi S, Oh H, Kim J, Lee J, et al. In vivo reactive astrocyte imaging in patients with schizophrenia using fluorine 18\u2013Labeled THK5351. JAMA Netw Open. 2024;7:e2410684.","journal-title":"JAMA Netw Open"},{"key":"2816_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0306-4522(96)83013-2","volume":"70","author":"J Saura","year":"1996","unstructured":"Saura J, Bleuel Z, Ulrich J, Mendelowitsch A, Chen K, Shih JC, et al. Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry. Neuroscience. 1996;70:755\u201374.","journal-title":"Neuroscience"},{"key":"2816_CR10","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1523\/JNEUROSCI.12-05-01977.1992","volume":"12","author":"J Saura","year":"1992","unstructured":"Saura J, Kettler R, Da Prada M, Richards JG. Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain. J Neurosci. 1992;12:1977\u201399.","journal-title":"J Neurosci"},{"key":"2816_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/265080a0","volume":"265","author":"V Glover","year":"1977","unstructured":"Glover V, Sandler M, Owen F, Riley GJ. Dopamine is a monoamine oxidase B substrate in man. Nature. 1977;265:80\u20131.","journal-title":"Nature"},{"key":"2816_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/jcbfm.2013.19","volume":"33","author":"J Tong","year":"2013","unstructured":"Tong J, Meyer JH, Furukawa Y, Boileau I, Chang LJ, Wilson AA, et al. Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies. J Cereb Blood Flow Metab. 2013;33:863\u201371.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2816_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.biopsych.2011.10.009","volume":"71","author":"R Mizrahi","year":"2012","unstructured":"Mizrahi R, Addington J, Rusjan PM, Suridjan I, Ng A, Boileau I, et al. Increased stress-induced dopamine release in psychosis. Biol Psychiatry. 2012;71:561\u20137.","journal-title":"Biol Psychiatry"},{"key":"2816_CR14","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","volume":"69","author":"OD Howes","year":"2012","unstructured":"Howes OD, Kambeitz J, Kim E, Stahl D, Slifstein M, Abi-Dargham A, et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry. 2012;69:776\u201386.","journal-title":"Arch Gen Psychiatry"},{"key":"2816_CR15","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/npp.2013.347","volume":"39","author":"R Mizrahi","year":"2014","unstructured":"Mizrahi R, Kenk M, Suridjan I, Boileau I, George TP, McKenzie K, et al. Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use. Neuropsychopharmacology. 2014;39:1479\u201389.","journal-title":"Neuropsychopharmacology"},{"key":"2816_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/archgenpsychiatry.2008.514","volume":"66","author":"OD Howes","year":"2009","unstructured":"Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry. 2009;66:13\u201320.","journal-title":"Arch Gen Psychiatry"},{"key":"2816_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/mp.2009.108","volume":"16","author":"P Fusar-Poli","year":"2011","unstructured":"Fusar-Poli P, Howes OD, Allen P, Broome M, Valli I, Asselin MC, et al. Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Mol Psychiatry. 2011;16:67\u201375.","journal-title":"Mol Psychiatry"},{"key":"2816_CR18","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.3390\/ijms23084453","volume":"23","author":"MH Nam","year":"2022","unstructured":"Nam MH, Sa M, Ju YH, Park MG, Lee CJ. Revisiting the role of Astrocytic MAOB in Parkinson\u2019s Disease. Int J Mol Sci. 2022;23:4453.","journal-title":"Int J Mol Sci"},{"key":"2816_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0306-4522(94)90311-5","volume":"62","author":"J Saura","year":"1994","unstructured":"Saura J, Luque JM, Cesura AM, Da Prada M, Chan-Palay V, Huber G, et al. Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience. 1994;62:15\u201330.","journal-title":"Neuroscience"},{"key":"2816_CR20","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/brain\/awx172","volume":"140","author":"J Tong","year":"2017","unstructured":"Tong J, Rathitharan G, Meyer JH, Furukawa Y, Ang LC, Boileau I, et al. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders. Brain. 2017;140:2460\u201374.","journal-title":"Brain"},{"key":"2816_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF01253093","volume":"52","author":"CJ Fowler","year":"1981","unstructured":"Fowler CJ, Carlsson A, Winblad B. Monoamine oxidase-A and -B activities in the brain stem of schizophrenics and non-schizophrenic psychotics. J Neural Transm. 1981;52:23\u201332.","journal-title":"J Neural Transm"},{"key":"2816_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1192\/bjp.151.4.514","volume":"151","author":"F Owen","year":"1987","unstructured":"Owen F, Crow TJ, Frith CD, Johnson JA, Johnstone EC, Lofthouse R, et al. Selective decreases in MAO-B activity in post-mortem brains from schizophrenic patients with type II syndrome. Br J Psychiatry. 1987;151:514\u20139.","journal-title":"Br J Psychiatry"},{"key":"2816_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF01249088","volume":"65","author":"JJ Mann","year":"1986","unstructured":"Mann JJ, Kaplan RD, Bird ED. Elevated postmortem monoamine oxidase B activity in the caudate nucleus in Huntington\u2019s disease compared to schizophrenics and controls. J Neural Transm. 1986;65:277\u201383.","journal-title":"J Neural Transm"},{"key":"2816_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/archpsyc.1981.01780310063006","volume":"38","author":"ReveleyMA Glover","year":"1981","unstructured":"Glover ReveleyMA, Sandler V, Spokes M. EG. Brain monoamine oxidase activity in schizophrenics and controls. Arch Gen Psychiatry. 1981;38:663\u20135.","journal-title":"Arch Gen Psychiatry"},{"key":"2816_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/archpsyc.1974.01760160097020","volume":"31","author":"MA Schwartz","year":"1974","unstructured":"Schwartz MA, Wyatt RJ, Yang HY, Neff NH. Multiple forms of brain monoamine oxidase in schizophrenic and normal individuals. Arch Gen Psychiatry. 1974;31:557\u201360.","journal-title":"Arch Gen Psychiatry"},{"key":"2816_CR26","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1177\/0004867414531078","volume":"48","author":"VS Catts","year":"2014","unstructured":"Catts VS, Wong J, Fillman SG, Fung SJ, Shannon Weickert C. Increased expression of astrocyte markers in schizophrenia: association with neuroinflammation. Aust N Z J Psychiatry. 2014;48:722\u201334.","journal-title":"Aust N Z J Psychiatry"},{"key":"2816_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fncel.2016.00046","volume":"10","author":"K Sch\u00fcmberg","year":"2016","unstructured":"Sch\u00fcmberg K, Polyakova M, Steiner J, Schroeter ML. Serum S100B is related to illness duration and clinical symptoms in schizophrenia\u2014a meta-regression analysis. Front Cell Neurosci. 2016;10:46.","journal-title":"Front Cell Neurosci"},{"key":"2816_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00406-013-0482-4","volume":"264","author":"M Williams","year":"2014","unstructured":"Williams M, Pearce RKB, Hirsch SR, Ansorge O, Thom M, Maier M. Fibrillary astrocytes are decreased in the subgenual cingulate in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2014;264:357\u201362.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2816_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00406-013-0479-z","volume":"264","author":"MR Williams","year":"2014","unstructured":"Williams MR, Galvin K, O\u2019Sullivan B, MacDonald CD, Ching EWK, Turkheimer F, et al. Neuropathological changes in the substantia nigra in schizophrenia but not depression. Eur Arch Psychiatry Clin Neurosci. 2014;264:285\u201396.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2816_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.schres.2008.04.032","volume":"103","author":"AE Steffek","year":"2008","unstructured":"Steffek AE, McCullumsmith RE, Haroutunian V, Meador-Woodruff JH. Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in Schizophrenia. Schizophr Res. 2008;103:71\u201382.","journal-title":"Schizophr Res"},{"key":"2816_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-3-031-21054-9_14","volume":"30","author":"K Nisha Aji","year":"2023","unstructured":"Nisha Aji K, Meyer JH, Rusjan PM, Mizrahi R. Monoamine Oxidase B (MAO-B): a target for rational drug development in schizophrenia using PET imaging as an example. Adv Neurobiol. 2023;30:335\u201362.","journal-title":"Adv Neurobiol"},{"key":"2816_CR32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/379733a0","volume":"379","author":"JS Fowler","year":"1996","unstructured":"Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature. 1996;379:733\u20136.","journal-title":"Nature"},{"key":"2816_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00702-023-02716-4","volume":"131","author":"LM Holt","year":"2024","unstructured":"Holt LM, Nestler EJ. Astrocytic transcriptional and epigenetic mechanisms of drug addiction. J Neural Transm. 2024;131:409\u201324.","journal-title":"J Neural Transm"},{"key":"2816_CR34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/syn.890180203","volume":"18","author":"JS Fowler","year":"1994","unstructured":"Fowler JS, Volkow ND, Logan J, Wang GJ, MacGregor RR, Schyler D, et al. Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawal. Synapse. 1994;18:86\u201393.","journal-title":"Synapse"},{"key":"2816_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/syn.20703","volume":"64","author":"W Saba","year":"2010","unstructured":"Saba W, Valette H, Peyronneau MA, Bramoull\u00e9 Y, Coulon C, Curet O, et al. [(11)C]SL25.1188, a new reversible radioligand to study the monoamine oxidase type B with PET: preclinical characterisation in nonhuman primate. Synapse. 2010;64:61\u20139.","journal-title":"Synapse"},{"key":"2816_CR36","doi-asserted-by":"publisher","first-page":"9364","DOI":"10.1021\/ja00181a044","volume":"112","author":"KS Gates","year":"1990","unstructured":"Gates KS, Silverman RB. 5-(Aminomethyl)-3-aryl-2-oxazolidinones. A novel class of mechanism-based inactivators of monoamine oxidase B. J Am Chem Soc. 1990;112:9364\u201372.","journal-title":"J Am Chem Soc"},{"key":"2816_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/jlcr.1492","volume":"51","author":"Y Bramoull\u00e9","year":"2008","unstructured":"Bramoull\u00e9 Y, Puech F, Saba W, Valette H, Bottlaender M, George P. et al. Radiosynthesis of (S)-5-methoxymethyl-3-[6-(4,4,4-trifluorobutoxy)benzo[d]isoxazol-3-yl] oxazolidin-2-[11C]one ([11C]SL25.1188), a novel radioligand for imaging monoamine oxidase-B with PET. J Label Compd Radiopharm. 2008;51:153\u20138.","journal-title":"J Label Compd Radiopharm"},{"key":"2816_CR38","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/jcbfm.2014.34","volume":"34","author":"PM Rusjan","year":"2014","unstructured":"Rusjan PM, Wilson AA, Miler L, Fan I, Mizrahi R, Houle S, et al. Kinetic modeling of the monoamine oxidase B radioligand [11C]SL25.1188 in human brain with high-resolution positron emission tomography. J Cereb Blood Flow Metab. 2014;34:883\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2816_CR39","unstructured":"Curet O, Sontag N, Aubin N, Marc C, Jegham S, George PB, et al. Biochemical profile of SL25.1188, a new reversi- ble MAO-B inhibitor. In Proceedings of the 29th annual meeting of society neuroscience. 1999. p. 848\u201314."},{"key":"2816_CR40","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.biopsych.2022.06.017","volume":"92","author":"OD Howes","year":"2022","unstructured":"Howes OD, Shatalina E. Integrating the neurodevelopmental and dopamine hypotheses of Schizophrenia and the role of cortical excitation-inhibition balance. Biol Psychiatry. 2022;92:501\u201313.","journal-title":"Biol Psychiatry"},{"key":"2816_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/wps.20693","volume":"19","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon RA, Krystal JH, Howes OD. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. World Psychiatry. 2020;19:15\u201333.","journal-title":"World Psychiatry"},{"key":"2816_CR42","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.biopsych.2020.05.028","volume":"89","author":"P Plav\u00e9n-Sigray","year":"2021","unstructured":"Plav\u00e9n-Sigray P, Matheson GJ, Coughlin JM, Hafizi S, Laurikainen H, Ottoy J, et al. Meta-analysis of the Glial Marker TSPO in psychosis revisited: reconciling inconclusive findings of patient\u2013control differences. Biol Psychiatry. 2021;89:e5\u20138.","journal-title":"Biol Psychiatry"},{"key":"2816_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/toxics10020048","volume":"10","author":"E Landucci","year":"2022","unstructured":"Landucci E, Mazzantini C, Lana D, Giovannini MG, Pellegrini-Giampietro DE. Neuronal and astrocytic morphological alterations driven by prolonged exposure with \u03949-Tetrahydrocannabinol but not cannabidiol. Toxics. 2022;10:48.","journal-title":"Toxics"},{"key":"2816_CR44","first-page":"35","volume":"38","author":"O Dosumu","year":"2021","unstructured":"Dosumu O, Owolabi O, Ugbaja R, Popoola A, Rotimi S, Taiwo O, et al. Administration of cannabis causes alterations in monoamine oxidase B and serotonin receptor 2c gene expressions in wistar rats. Acta Facultatis Medicae Naissensis. 2021;38:35\u201346.","journal-title":"Acta Facultatis Medicae Naissensis"},{"key":"2816_CR45","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00210-010-0517-6","volume":"381","author":"Z Fisar","year":"2010","unstructured":"Fisar Z. Inhibition of monoamine oxidase activity by cannabinoids. Naunyn-Schmiedeberg\u2019s. Archiv Pharmacol. 2010;381:563\u201372.","journal-title":"Archiv Pharmacol"},{"key":"2816_CR46","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/schbul\/sbx180","volume":"44","author":"R McCutcheon","year":"2018","unstructured":"McCutcheon R, Beck K, Jauhar S, Howes OD. Defining the locus of dopaminergic dysfunction in Schizophrenia: a meta-analysis and test of the mesolimbic hypothesis. Schizophr Bull. 2018;44:1301\u201311.","journal-title":"Schizophr Bull"},{"key":"2816_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38530-5","volume":"14","author":"M Maitra","year":"2023","unstructured":"Maitra M, Mitsuhashi H, Rahimian R, Chawla A, Yang J, Fiori LM, et al. Cell type specific transcriptomic differences in depression show similar patterns between males and females but implicate distinct cell types and genes. Nat Commun. 2023;14:2912.","journal-title":"Nat Commun"},{"key":"2816_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-024-01128-z","volume":"17","author":"M Dehestani","year":"2024","unstructured":"Dehestani M, Kozareva V, Blauwendraat C, Fraenkel E, Gasser T, Bansal V. Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson\u2019s disease. Mol Brain. 2024;17:56.","journal-title":"Mol Brain"},{"key":"2816_CR49","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1523\/JNEUROSCI.2074-20.2021","volume":"41","author":"S Malaiya","year":"2021","unstructured":"Malaiya S, Cortes-Gutierrez M, Herb BR, Coffey SR, Legg SRW, Cantle JP, et al. Single-nucleus RNA-Seq reveals dysregulation of striatal cell identity due to huntington\u2019s disease mutations. J Neurosci. 2021;41:5534\u201352.","journal-title":"J Neurosci"},{"key":"2816_CR50","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.euroneuro.2021.10.006","volume":"54","author":"T Gill","year":"2022","unstructured":"Gill T, Watling SE, Richardson JD, McCluskey T, Tong J, Meyer JH, et al. Imaging of astrocytes in posttraumatic stress disorder: a PET study with the monoamine oxidase B radioligand [11C]SL25.1188. Eur Neuropsychopharmacol. 2022;54:54\u201361.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2816_CR51","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1001\/jamapsychiatry.2019.0044","volume":"76","author":"S Moriguchi","year":"2019","unstructured":"Moriguchi S, Wilson AA, Miler L, Rusjan PM, Vasdev N, Kish SJ, et al. Monoamine Oxidase B total distribution volume in the prefrontal cortex of major depressive disorder: an [11C]SL25.1188 positron emission tomography study. JAMA Psychiatry. 2019;76:634\u201341. Jun 1","journal-title":"JAMA Psychiatry"},{"key":"2816_CR52","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1093\/brain\/awad279","volume":"146","author":"Y Koshimori","year":"2023","unstructured":"Koshimori Y, Cusimano MD, Vieira EL, Rusjan PM, Kish SJ, Vasdev N, et al. Astrogliosis marker 11C-SL25.1188 PET in traumatic brain injury with persistent symptoms. Brain. 2023;146:4469\u201375.","journal-title":"Brain"},{"key":"2816_CR53","unstructured":"First MB, Williams JBW, KargRS, Spitzer RL. Structured Clinical Interview for DSM-5\u2014 Research Version(SCID-5 for DSM-5, Research Version; SCID-5-RV, Version 1.0.0). Arlington, VA, American Psychiatric Association, 2015."},{"key":"2816_CR54","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","volume":"67","author":"NC Andreasen","year":"2010","unstructured":"Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry. 2010;67:255\u201362.","journal-title":"Biol Psychiatry"},{"key":"2816_CR55","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1176\/appi.ajp.159.5.863","volume":"159","author":"TJ Miller","year":"2002","unstructured":"Miller TJ, McGlashan TH, Rosen JL, Somjee L, Markovich PJ, Stein K, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry. 2002;159:863\u20135.","journal-title":"Am J Psychiatry"},{"key":"2816_CR56","unstructured":"First MB, Gibbon M. The structured clinical interview for DSM-IV Axis I Disorders (SCID-I) and the structured clinical interview for DSM-IV Axis II Disorders (SCID-II). In: Comprehensive handbook of psychological assessment, Vol 2: Personality assessment. Hoboken, NJ, US: John Wiley & Sons, Inc.; 2004. p. 134\u201343."},{"key":"2816_CR57","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261\u201376.","journal-title":"Schizophr Bull"},{"key":"2816_CR58","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.schres.2007.06.013","volume":"95","author":"L Holzer","year":"2007","unstructured":"Holzer L, Chinet L, Jaugey L, Plancherel B, Sofia C, Halfon O, et al. Detection of cognitive impairment with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in adolescents with psychotic symptomatology. Schizophr Res. 2007;95:48\u201353.","journal-title":"Schizophr Res"},{"key":"2816_CR59","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1111\/bph.15067","volume":"177","author":"P Rusjan","year":"2020","unstructured":"Rusjan P, Sabioni P, Di Ciano P, Mansouri E, Boileau I, Laveill\u00e9 A, et al. Exploring occupancy of the histamine H3 receptor by pitolisant in humans using PET. Br J Pharmacol. 2020;177:3464\u201372.","journal-title":"Br J Pharmacol"},{"key":"2816_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pscychresns.2006.01.011","volume":"147","author":"P Rusjan","year":"2006","unstructured":"Rusjan P, Mamo D, Ginovart N, Hussey D, Vitcu I, Yasuno F, et al. An automated method for the extraction of regional data from PET images. Psychiatry Res. 2006;147:79\u201389.","journal-title":"Psychiatry Res"},{"key":"2816_CR61","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","volume":"10","author":"J Logan","year":"1990","unstructured":"Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ. et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2816_CR62","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u20133587.e29.","journal-title":"Cell"},{"key":"2816_CR63","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.WCB.0000048520.34839.1A","volume":"23","author":"D Martinez","year":"2003","unstructured":"Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y, et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab. 2003;23:285\u2013300.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2816_CR64","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/archpsyc.60.6.572","volume":"60","author":"K Hashimoto","year":"2003","unstructured":"Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, et al. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry. 2003;60:572\u20136.","journal-title":"Arch Gen Psychiatry"},{"key":"2816_CR65","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.schres.2006.10.010","volume":"90","author":"I Bendikov","year":"2007","unstructured":"Bendikov I, Nadri C, Amar S, Panizzutti R, De MirandaJ, Wolosker H, et al. A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia. Schizophr Res. 2007;90:41\u201351.","journal-title":"Schizophr Res"},{"key":"2816_CR66","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3389\/fpsyt.2020.00764","volume":"11","author":"JJ Watts","year":"2020","unstructured":"Watts JJ, Garani R, Da Silva T, Lalang N, Chavez S, Mizrahi R. Evidence that cannabis exposure, abuse, and dependence are related to glutamate metabolism and glial function in the anterior cingulate cortex: a 1H-Magnetic resonance spectroscopy study. Front Psychiatry. 2020;11:764.","journal-title":"Front Psychiatry"},{"key":"2816_CR67","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1001\/jamapsychiatry.2019.2516","volume":"76","author":"T Da Silva","year":"2019","unstructured":"Da Silva T, Hafizi S, Watts JJ, Weickert CS, Meyer JH, Houle S, et al. In vivo imaging of translocator protein in long-term cannabis users. JAMA Psychiatry. 2019;76:1305\u201313.","journal-title":"JAMA Psychiatry"},{"key":"2816_CR68","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pscychresns.2010.10.005","volume":"191","author":"MM Silveri","year":"2011","unstructured":"Silveri MM, Jensen JE, Rosso IM, Sneider JT, Yurgelun-Todd DA. Preliminary evidence for white matter metabolite differences in marijuana-dependent young men using 2D J-resolved magnetic resonance spectroscopic imaging at 4 Tesla. Psychiatry Res. 2011;191:201\u201311.","journal-title":"Psychiatry Res"},{"key":"2816_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24355-6","volume":"8","author":"T Da Silva","year":"2018","unstructured":"Da Silva T, Wu A, Laksono I, Prce I, Maheandiran M, Kiang M, et al. Mitochondrial function in individuals at clinical high risk for psychosis. Sci Rep. 2018;8:6216.","journal-title":"Sci Rep"},{"key":"2816_CR70","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1001\/jamapsychiatry.2021.3710","volume":"79","author":"R Basavaraju","year":"2022","unstructured":"Basavaraju R, Guo J, Small SA, Lieberman JA, Girgis RR, Provenzano FA. Hippocampal glutamate and positive symptom severity in clinical high risk for psychosis. JAMA Psychiatry. 2022;79:178\u20139.","journal-title":"JAMA Psychiatry"},{"key":"2816_CR71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","volume":"9","author":"KP Ng","year":"2017","unstructured":"Ng KP, Pascoal TA, Mathotaarachchi S, Therriault J, Kang MS, Shin M, et al. Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain. Alzheimers Res Ther. 2017;9:25.","journal-title":"Alzheimers Res Ther"},{"key":"2816_CR72","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/mp.2012.109","volume":"18","author":"JL Thompson","year":"2013","unstructured":"Thompson JL, Urban N, Slifstein M, Xu X, Kegeles LS, Girgis RR, et al. Striatal dopamine release in schizophrenia comorbid with substance dependence. Mol Psychiatry. 2013;18:909\u201315.","journal-title":"Mol Psychiatry"},{"key":"2816_CR73","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/ijnp\/pyx094","volume":"21","author":"T Da Silva","year":"2018","unstructured":"Da Silva T, Hafizi S, Andreazza AC, Kiang M, Bagby RM, Navas E, et al. Glutathione, the major redox regulator, in the prefrontal cortex of individuals at clinical high risk for psychosis. Int J Neuropsychopharmacol. 2018;21:311\u20138.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2816_CR74","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/ijnp\/pyad012","volume":"26","author":"D Dwir","year":"2023","unstructured":"Dwir D, Khadimallah I, Xin L, Rahman M, Du F, \u00d6ng\u00fcr D, et al. Redox and immune signaling in schizophrenia: new therapeutic potential. Int J Neuropsychopharmacol. 2023;26:309\u201321.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2816_CR75","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3390\/molecules24081560","volume":"24","author":"N Kopjar","year":"2019","unstructured":"Kopjar N, Fuchs N, \u017dunec S, Mikoli\u0107 A, Micek V, Kozina G, et al. DNA damaging effects, oxidative stress responses and cholinesterase activity in blood and brain of wistar rats exposed to \u03949-Tetrahydrocannabinol. Molecules. 2019;24:1560.","journal-title":"Molecules"},{"key":"2816_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111988","volume":"42","author":"O Pietil\u00e4inen","year":"2023","unstructured":"Pietil\u00e4inen O, Trehan A, Meyer D, Mitchell J, Tegtmeyer M, Valakh V, et al. Astrocytic cell adhesion genes linked to schizophrenia correlate with synaptic programs in neurons. Cell Rep. 2023;42:111988.","journal-title":"Cell Rep"},{"key":"2816_CR77","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41586-024-07109-5","volume":"627","author":"E Ling","year":"2024","unstructured":"Ling E, Nemesh J, Goldman M, Kamitaki N, Reed N, Handsaker RE, et al. A concerted neuron-astrocyte program declines in ageing and schizophrenia. Nature. 2024;627:604\u201311.","journal-title":"Nature"},{"key":"2816_CR78","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/schbul\/sbad033","volume":"49","author":"L Levi","year":"2023","unstructured":"Levi L, Bar-Haim M, Winter-van Rossum I, Davidson M, Leucht S, Fleischhacker WW, et al. Cannabis use and symptomatic relapse in first episode schizophrenia: trigger or consequence? Data from the OPTIMISE study. Schizophr Bull. 2023;49:903\u201313.","journal-title":"Schizophr Bull"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02816-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02816-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02816-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:02:17Z","timestamp":1789113737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02816-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["2816"],"URL":"https:\/\/doi.org\/10.1038\/s41380-024-02816-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4058038\/v1","asserted-by":"object"}]},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"9 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NL is an employee at the Vertex Pharmaceuticals and the authors collectively declare that they have no financial relationships with commercial interests that could have appeared to influence the work reported in this paper. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}